Changes in protein expression during multistage mouse skin carcinogenesis.
To directly compare the expression patterns of different proteins known to be altered during mouse skin carcinogenesis, serial sections of normal and hyperplastic skin and tumors from various stages of 7,12-dimethylbenz[a]anthracene-initiated, 12-O-tetradecanoylphorbol-13-acetate-promoted female SENCAR mice were examined by immunohistochemistry. In untreated, normal mouse skin, keratin 1 (K1) and transforming growth factor-beta1 (TGFbeta1) were strongly expressed in the suprabasal layers, whereas integrin alpha6beta4 was expressed only in basal cells and only moderate staining for transforming growth factor-alpha (TGFalpha) was seen. In hyperplastic skin, TGFalpha expression became stronger, whereas expression of another epidermal growth factor (EGF) receptor ligand, heparin-binding EGF-like growth factor (HB-EGF), was strongly induced in all epidermal layers from no expression in normal skin. Likewise, the gap-junctional protein connexin 26 (Cx26) became highly expressed in the differentiated granular layers of hyperplastic skin relative to undetectable expression in normal skin. Expression of cyclin D1 in the proliferative cell compartment was seen in all benign and malignant tumors but not in hyperplastic skin. Beginning with very early papillomas (after 10 wk of promotion), expression of alpha6beta4 in suprabasal cells and small, focal staining for keratin 13 (K13) were seen in some tumors. Later (after 20-30 wk), focal areas of gamma-glutamyl transpeptidase (GGT) activity appeared in a few papillomas, whereas TGFbeta1 expression began to decrease. Cx26 and TGFalpha staining became patchier in some late-stage papillomas (30-40 wk), whereas suprabasal alpha6beta4, K13, and GGT expression progressively increased and K1 expression decreased. Finally, in squamous cell carcinomas (SCCs), there was an almost complete loss of K1 and a further decline in TGFalpha, HB-EGF, TGFbeta1, and Cx26 expression. On the other hand, almost all SCCs showed suprabasal staining for alpha6beta4 and widespread cyclin D1 and K13 expression, whereas only about half showed positive focal staining for GGT activity.
Rundhaug
J E
JE
The University of Texas M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78957, USA.
Gimenez-Conti
I
I
Stern
M C
MC
Budunova
I V
IV
Kiguchi
K
K
Bol
D K
DK
Coghlan
L G
LG
Conti
C J
CJ
DiGiovanni
J
J
Fischer
S M
SM
Winberg
L D
LD
Slaga
T J
TJ
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D000954:Antigens, Surface / Q000096:biosynthesis; D002273:Carcinogens; D000072259:Connexin 26; D017630:Connexins / Q000096:biosynthesis; D019938:Cyclin D1; D016213:Cyclins / Q000096:biosynthesis; D004815:Epidermal Growth Factor / Q000096:biosynthesis; D005260:Female; D066257:Heparin-binding EGF-like Growth Factor; D039161:Integrin alpha6beta4; D016023:Integrins / Q000096:biosynthesis; D036341:Intercellular Signaling Peptides and Proteins; D007633:Keratins / Q000096:biosynthesis; D051379:Mice; D018632:Mice, Inbred SENCAR; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D015513:Oncogene Proteins / Q000096:biosynthesis; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate; D016211:Transforming Growth Factor alpha / Q000096:biosynthesis; D005723:gamma-Glutamyltransferase / Q000096:biosynthesis
D000954:Antigens, Surface; D002273:Carcinogens; D017630:Connexins; D016213:Cyclins; C000607043:Gjb2 protein, mouse; C587884:Hbegf protein, mouse; D066257:Heparin-binding EGF-like Growth Factor; D039161:Integrin alpha6beta4; D016023:Integrins; D036341:Intercellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; D015513:Oncogene Proteins; D016211:Transforming Growth Factor alpha; D000072259:Connexin 26; D019938:Cyclin D1; D015127:9,10-Dimethyl-1,2-benzanthracene; D004815:Epidermal Growth Factor; D007633:Keratins; D005723:gamma-Glutamyltransferase; D013755:Tetradecanoylphorbol Acetate